New Approaches, New Hope

OncoSec is a late-stage biotechnology company developing immunotherapy cancer treatments using our plasmid DNA delivery platform. Through our proprietary technology, we hope to deliver safer and more effective cancer treatments that can provide long-term benefits for patients.  

We leverage a fully-integrated immune-oncology platform:

Clinical Pipeline

Our core technology platform continues to advance through clinical trials for various cancers


Our plasmid DNA delivery platform is designed to boost the body’s immune system to target and attack cancer


We have a track record of establishing, operating and evolving high-performance partnerships globally